Missouri & Illinois Personal Injury Attorneys
Call 24/7 800.391.4318
Johnson & Johnson Talcum Powder Claims Expand to Canada

Johnson & Johnson Talcum Powder Claims Expand to Canada

An another class-action lawsuit has been filed against the pharmaceutical giant, Johnson & Johnson. This time, the lawsuits are coming from Canada. A number of Canadian women claim their ovarian cancer was caused by their long time use of Johnson & Johnson’s popular Baby Powder. The Canadian plaintiffs include seven women as well as the family of a woman who died of ovarian cancer this past March. The women are being represented by two Toronto law firms. The suit accuses Johnson & Johnson Canada of negligence in the development of Johnson’s Baby Powder, as well as negligence in the testing, design, manufacturing, licensing, distribution, and marketing. The Johnson & Johnson Canada admits no wrongdoing and stands by its Baby Powder.

Jurors in St. Louis, Missouri, have found Johnson & Johnson guilty of negligence as well as knowing the dangers of talcum powder and concealing it. This decision will set a precedent for more than 1,200 pending claims against the billion dollar company. Johnson & Johnson has already been ordered by the courts to pay millions to plaintiffs. Over the next several months, more cases against Johnson & Johnson will be heard across the country. If you believe you are a victim of Johnson & Johnson’s harmful actions, please contact St. Louis’ best product liability attorneys at Meyerkord and Meyerkord, LLC. While the law firm of Meyerkord and Meyerkord, LLC, practices in St. Louis, the product liability attorneys have help victims from all over the country. To schedule an initial consultation at no-cost, please call our downtown St. Louis location today.

Categories:

Take the First Step Towards Recovery

Put Experience On Your Side Today
    • Please enter your name.
    • This isn't a valid phone number.
    • Please enter your email address.
      This isn't a valid email address.
    • Please make a selection.
    • Please enter a message.